Displaying One Session

Educational session

Realising potential combination and personalised therapy

Session Track
Genitourinary tumours, non-prostate
Chairs
  • Thomas B. Powles (London, United Kingdom)
Release Date
Thu, 16.09.2021

Is there an optimal first-line combination approach for metastatic mRCC? (ID 143)

Speakers
  • Toni K. Choueiri (Boston, United States of America)
Duration
15 Minutes

Current status of personalised therapy in metastatic mRCC (ID 144)

Speakers
  • Manuela Schmidinger (Vienna, Austria)
Duration
15 Minutes

Future targets and combinations for mRCC (ID 145)

Speakers
  • Cristina Suarez Rodriguez (Barcelona, Spain)
Duration
15 Minutes